163 related articles for article (PubMed ID: 31295053)
1. A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service.
Cocoman AM; Gallagher D
Issues Ment Health Nurs; 2019 Oct; 40(10):895-901. PubMed ID: 31295053
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
[TBL] [Abstract][Full Text] [Related]
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
[TBL] [Abstract][Full Text] [Related]
5. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
[TBL] [Abstract][Full Text] [Related]
6. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia.
Eskelinen S; Sailas E; Joutsenniemi K; Holi M; Suvisaari J
Nord J Psychiatry; 2015 Jul; 69(5):339-45. PubMed ID: 25981178
[TBL] [Abstract][Full Text] [Related]
7. Metabolic monitoring and management among clozapine users.
Tso G; Kumar P; Jayasooriya T; Kisely S; Siskind D
Australas Psychiatry; 2017 Feb; 25(1):48-52. PubMed ID: 27590080
[TBL] [Abstract][Full Text] [Related]
8. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
[TBL] [Abstract][Full Text] [Related]
9. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
[TBL] [Abstract][Full Text] [Related]
10. Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication.
Morell R; Curtis J; Watkins A; Poole J; Fibbins H; Rossimel E; Gerrard M; White A; Teasdale S; Ward PB; Lappin J
Psychiatry Res; 2019 Nov; 281():112606. PubMed ID: 31629301
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness.
de Caluwé L; van Buitenen N; Gelan PJ; Crunelle CL; Thomas R; Casseres S; Matthys F; van Harten P; Cahn W
Psychiatry Res; 2019 Nov; 281():112558. PubMed ID: 31546147
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
Zhang Y; Chen M; Chen J; Wu Z; Yu S; Fang Y; Zhang C
Psychopharmacology (Berl); 2014 May; 231(10):2211-8. PubMed ID: 24448899
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
Bai YM; Chen JY; Yang WS; Chi YC; Liou YJ; Lin CC; Wang YC; Lin CY; Su TP; Chou P
J Clin Psychiatry; 2007 Dec; 68(12):1834-9. PubMed ID: 18162013
[TBL] [Abstract][Full Text] [Related]
16. Routine screening and rates of metabolic syndrome in patients treated with clozapine and long-acting injectable antipsychotic medications: a cross-sectional study.
Lydon A; Vallely J; Tummon A; Maher S; Sabri S; McLoughlin J; Liew A; McDonald C; Hallahan B
Ir J Psychol Med; 2021 Mar; 38(1):40-48. PubMed ID: 32204737
[TBL] [Abstract][Full Text] [Related]
17. Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort.
Xing M; Sheng J; Cui M; Su Y; Zhang C; Chen X; Fang Y; Cui D; Li Z
Curr Neuropharmacol; 2022; 20(10):1969-1977. PubMed ID: 35236263
[TBL] [Abstract][Full Text] [Related]
18. Improving and standardizing metabolic screening for people prescribed antipsychotic medication who are at risk of developing metabolic syndrome within the community mental health setting.
Hackett D; Fitzgerald C
Int J Ment Health Nurs; 2020 Oct; 29(5):935-941. PubMed ID: 32567189
[TBL] [Abstract][Full Text] [Related]
19. Very low rates of screening for metabolic syndrome among patients with severe mental illness in Durban, South Africa.
Saloojee S; Burns JK; Motala AA
BMC Psychiatry; 2014 Aug; 14():228. PubMed ID: 25113131
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
